Next 10 |
2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...
2023-05-03 13:05:45 ET Gainers: ImmunoGen ( IMGN ) +124% . GD Culture Group Limited ( GDC ) +115% . Aptorum Group Limited ( APM ) +92% . Aceragen ( ACGN ) +77% . NantHealth ( NH ) +57% . Sentage Holdings ( SNTG ) +61% ...
HITRUST Certification validates NantHealth’s commitment to aligning with key regulations and protecting sensitive information NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its E...
2023-03-06 09:20:36 ET NantHealth ( NASDAQ: NH ) entered into a credit agreement for a new senior secured term loan in principal amount of $22.5M. Net proceeds to be used for funding its existing businesses and for general corporate purposes. The term loan facility was...
NantHealth , Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the entry into a credit agreement for a new senior secured term loan in an aggregate principal amount of $22.5 million. The company...
Meridian 2023 is a look into the future of network monitoring, centered around simplification The OpenNMS Group, Inc ., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the release of OpenNMS Meridian 2023 . With this major release, the fully open source Meri...
NantHealth , Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company has implemented a reverse stock split at a ratio of 1-for-15, which is expected to be effective 5 p.m. Eastern Tim...
NantHealth, Inc. (NH) Q3 2022 Earnings Conference Call November 03, 2022 04:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Present...
NantHealth press release ( NASDAQ: NH ): Q3 Non-GAAP EPS of -$0.12. Revenue of $16.6M (+15.3% Y/Y). For further details see: NantHealth Non-GAAP EPS of -$0.12, revenue of $16.6M
Q3 2022 Financial and Operational Highlights: Total net revenue was $16.6 million Gross profit was $9.7 million, or 58% of total revenue The company’s Eviti Connect platform earned full URAC accreditation for Health Utilization Management, through 2025 Maryl...
News, Short Squeeze, Breakout and More Instantly...
HITRUST Certification validates NantHealth’s commitment to aligning with key regulations and protecting sensitive information NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its E...
NantHealth , Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the entry into a credit agreement for a new senior secured term loan in an aggregate principal amount of $22.5 million. The company...
Meridian 2023 is a look into the future of network monitoring, centered around simplification The OpenNMS Group, Inc ., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the release of OpenNMS Meridian 2023 . With this major release, the fully open source Meri...